Mint Tower Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Mint Tower Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-28,731	Closed	-$971K	–	416
2021 Q2	$971K	Buy	+28,731	New	+$732K	0.07%	200

Mint Tower Capital Management's CNST Position: Q3 2021 in Review

Mint Tower Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 28,731 shares — an estimated $971K sold.

Mint Tower Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $971K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Mint Tower Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Mint Tower Capital Management sold 28,731 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $971K.
Mint Tower Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Mint Tower Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $971K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Mint Tower Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.